Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)

Last updated: February 12, 2026
Sponsor: Wake Forest University Health Sciences
Overall Status: Active - Not Recruiting

Phase

1

Condition

Hair Loss

Alopecia

Treatment

usual medication for CCCA

azelaic acid

Clinical Study ID

NCT05416333
IRB00076717
  • Ages > 18
  • Female

Study Summary

The purpose of this pilot study is to determine if azelaic acid shows potential to be an effective treatment for Central Centrifugal Cicatricial Alopecia (CCCA). In this study, the aim is to compare azelaic acid vs placebo since azelaic acid may increase anti-inflammatory effects that affect the hair growth cycle.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • women eighteen years of age or older

  • biopsy-proven and /or clinical diagnosis of CCCA Stage II-IV

  • on stable treatment without changes for at least three months

  • recruited from outpatient dermatology clinics at the Wake Forest Baptist HealthDepartment of Dermatology

Exclusion

Exclusion Criteria:

  • males

Study Design

Total Participants: 18
Treatment Group(s): 2
Primary Treatment: usual medication for CCCA
Phase: 1
Study Start date:
August 12, 2024
Estimated Completion Date:
December 31, 2026

Study Description

The management of Central Centrifugal Cicatricial Alopecia (CCCA) is challenging due to limited current treatments and a lack of randomized controlled trials. Management focuses on behavioral and styling modifications, in addition to symptomatic relief. Any potentially damaging hair care practices such as chemical relaxers, heat application to the scalp, and the use of hardening gels and sprays are discouraged. Many commonly used therapies are anti-inflammatory in nature, including intralesional steroids, topical steroids, oral antibiotics and increased frequency of hair washing with antidandruff shampoos. These treatments not only lead to improvement in pruritus and tenderness, but in some cases result in increased hair density. Currently, comparison studies of different treatments for CCCA subjects is limited. The aim is to determine if there is an advantage in using one particular anti-inflammatory therapy over another for relieving symptoms and promoting hair follicle regrowth.

Connect with a study center

  • Wake Forest University Health Scieces

    Winston-Salem, North Carolina 27157
    United States

    Site Not Available

  • Wake Forest University Health Scieces

    Winston-Salem 4499612, North Carolina 4482348 27157
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.